Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Evaluation of Aminoglycoside Dosing Regimens Adjusted for Renal Function and In Vitro Susceptibility Test Interpretive Criteria for Enterobacterales and Pseudomonas aeruginosa.
Journal: Open forum infectious diseases
Published: May 23, 2025
Evaluation of Aminoglycoside Dosing Regimens Adjusted for Renal Function and In Vitro Susceptibility Test Interpretive Criteria for Enterobacterales and Pseudomonas aeruginosa: Brief Summary.
Journal: Open forum infectious diseases
Published: May 21, 2025
In vivo pharmacodynamics of lefamulin, the first systemic pleuromutilin for human use, in a neutropenic murine thigh infection model.
Journal: The Journal of antimicrobial chemotherapy
Published: April 06, 2019
Identification of the In Vivo Pharmacokinetics and Pharmacodynamic Driver of Iclaprim.
Journal: Antimicrobial agents and chemotherapy
Published: December 14, 2017
In vivo pharmacokinetics and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine thigh infection model.
Journal: Antimicrobial agents and chemotherapy
Published: December 17, 2014
Impact of MIC range for Pseudomonas aeruginosa and Streptococcus pneumoniae on the ceftolozane in vivo pharmacokinetic/pharmacodynamic target.
Journal: Antimicrobial agents and chemotherapy
Published: August 06, 2014
Editorial commentary: Are blood concentrations enough for establishing pharmacokinetic/pharmacodynamic relationships?
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 29, 2014
Failure of clindamycin to eradicate infection with beta-hemolytic streptococci inducibly resistant to clindamycin in an animal model and in human infections.
Journal: Antimicrobial agents and chemotherapy
Published: December 11, 2013
Background and rationale for revised clinical and laboratory standards institute interpretive criteria (Breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and Aztreonam.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 22, 2013
Inoculum effects of ceftobiprole, daptomycin, linezolid, and vancomycin with Staphylococcus aureus and Streptococcus pneumoniae at inocula of 10(5) and 10(7) CFU injected into opposite thighs of neutropenic mice.
Journal: Antimicrobial agents and chemotherapy
Published: January 09, 2013
In vivo activities of ceftolozane, a new cephalosporin, with and without tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae, including strains with extended-spectrum β-lactamases, in the thighs of neutropenic mice.
Journal: Antimicrobial agents and chemotherapy
Published: January 01, 2013
Comparative pharmacodynamics of the new oxazolidinone tedizolid phosphate and linezolid in a neutropenic murine Staphylococcus aureus pneumonia model.
Journal: Antimicrobial agents and chemotherapy
Published: September 12, 2012
Last Updated: 09/26/2026